TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Technique
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL ANTIBODY DRUG DISCOVERY MARKET, BY TYPE
6.1. Overview
6.2. Monoclonal Antibodies
6.3. Polyclonal Antibodies
6.4. Bispecific Antibodies
6.5. Intracellular Antibodies
7. GLOBAL ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE
7.1. Overview
7.2. Hybridoma
7.3. Phage Display
7.4. Others
8. GLOBAL ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION
8.1. Overview
8.2. Oncology
8.3. Cardiology
8.4. Infectious Diseases
8.5. Autoimmune Diseases
8.6. Others
9. GLOBAL ANTIBODY DRUG DISCOVERY MARKET, BY END USER
9.1. Overview
9.2. Pharmaceutical and Biotechnology Companies
9.3. Contract Research Organization
9.4. Academic & Research Institutes
10. GLOBAL ANTIBODY DRUG DISCOVERY MARKET, BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Antibody Drug Discovery Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Antibody Drug Discovery Market
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. COMPANY PROFILES
12.1. Charles River Laboratories
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Biocytogen Pharmaceuticals Co., Ltd
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Sartorius AG
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Genscript Biotech Corporation
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Creative Biolabs
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Twist Bioscience
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Fairjourney Biologics SA
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. ProteoGenix
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Absolute Antibody
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Sino Biological, Inc.
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL ANTIBODY DRUG DISCOVERY MARKET, SYNOPSIS, 2019–2032
TABLE 2 GLOBAL ANTIBODY DRUG DISCOVERY MARKET, ESTIMATES & FORECAST, 2019–2032 (USD BILLION)
TABLE 3 GLOBAL ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 4 GLOBAL ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 5 GLOBAL ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 6 GLOBAL ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 7 NORTH AMERICA: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 8 NORTH AMERICA: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 9 NORTH AMERICA: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 10 NORTH AMERICA: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 11 US: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 12 US: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 13 US: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 14 US: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 15 CANADA: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 16 CANADA: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 17 CANADA: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 18 CANADA: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 1 EUROPE: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 2 EUROPE: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 3 EUROPE: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 4 EUROPE: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 5 GERMANY: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 6 GERMANY: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 7 GERMANY: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 8 GERMANY: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 9 FRANCE: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 10 FRANCE: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 11 FRANCE: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 12 FRANCE: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 13 ITALY: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 14 ITALY: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 15 ITALY: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 16 ITALY: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 17 SPAIN: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 18 SPAIN: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 19 SPAIN: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 20 SPAIN: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 21 UK: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 22 UK: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 23 UK: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 24 UK: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 25 REST OF EUROPE: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 26 REST OF EUROPE: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 27 REST OF EUROPE: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 28 REST OF EUROPE: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 29 ASIA-PACIFIC: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 30 ASIA-PACIFIC: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 31 ASIA-PACIFIC: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 32 ASIA-PACIFIC: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 33 JAPAN: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 34 JAPAN: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 35 JAPAN: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 36 JAPAN: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 37 CHINA: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 38 CHINA: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 39 CHINA: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 40 CHINA: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 41 INDIA: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 42 INDIA: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 43 INDIA: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 44 INDIA: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 45 AUSTRALIA: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 46 AUSTRALIA: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 47 AUSTRALIA: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 48 AUSTRALIA: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 49 SOUTH KOREA: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 50 SOUTH KOREA: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 51 SOUTH KOREA: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 52 SOUTH KOREA: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 53 REST OF ASIA-PACIFIC: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 54 REST OF ASIA-PACIFIC: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 55 REST OF ASIA-PACIFIC: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 56 REST OF ASIA-PACIFIC: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 57 REST OF THE WORLD: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 58 REST OF THE WORLD: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 59 REST OF THE WORLD: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 60 REST OF THE WORLD: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 61 MIDDLE EAST: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 62 MIDDLE EAST: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 63 MIDDLE EAST: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 64 MIDDLE EAST: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 65 AFRICA: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 66 AFRICA: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 67 AFRICA: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 68 AFRICA: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 69 LATIN AMERICA: ANTIBODY DRUG DISCOVERY MARKET, BY TYPE, 2019–2032 (USD BILLION)
TABLE 70 LATIN AMERICA: ANTIBODY DRUG DISCOVERY MARKET, BY TECHNIQUE, 2019–2032 (USD BILLION)
TABLE 71 LATIN AMERICA: ANTIBODY DRUG DISCOVERY MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 72 LATIN AMERICA: ANTIBODY DRUG DISCOVERY MARKET, BY END USER, 2019–2032 (USD BILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ANTIBODY DRUG DISCOVERY MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ANTIBODY DRUG DISCOVERY MARKET
FIGURE 4 GLOBAL ANTIBODY DRUG DISCOVERY MARKET, SHARE (%), BY TYPE, 2022
FIGURE 5 GLOBAL ANTIBODY DRUG DISCOVERY MARKET, SHARE (%), BY TECHNIQUE, 2022
FIGURE 6 GLOBAL ANTIBODY DRUG DISCOVERY MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 7 GLOBAL ANTIBODY DRUG DISCOVERY MARKET, SHARE (%), BY END USER, 2022
FIGURE 8 GLOBAL ANTIBODY DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 NORTH AMERICA: ANTIBODY DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 EUROPE: ANTIBODY DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 ASIA-PACIFIC: ANTIBODY DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 REST OF THE WORLD: ANTIBODY DRUG DISCOVERY MARKET, SHARE (%), BY REGION, 2022
FIGURE 13 GLOBAL ANTIBODY DRUG DISCOVERY MARKET: COMPANY SHARE ANALYSIS (%), 2022
FIGURE 14 CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 CHARLES RIVER LABORATORIES: SWOT ANALYSIS
FIGURE 16 BIOCYTOGEN PHARMACEUTICALS CO., LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 BIOCYTOGEN PHARMACEUTICALS CO., LTD: SWOT ANALYSIS
FIGURE 18 SARTORIUS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 SARTORIUS AG: SWOT ANALYSIS
FIGURE 20 GENSCRIPT BIOTECH CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 GENSCRIPT BIOTECH CORPORATION: SWOT ANALYSIS
FIGURE 22 CREATIVE BIOLABS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 CREATIVE BIOLABS: SWOT ANALYSIS
FIGURE 24 TWIST BIOSCIENCE: FINANCIAL OVERVIEW SNAPSHO
